Background Coronary artery disease and disturbances of lipid levels are common in Arab countries.
Objective To assess homocysteine as a cardiovascular risk factor.
Method We compared 133 men with angiographically documented coronary heart disease with 130 age-matched asymptomatic men.
Results Cases had more hypertension and diabetes and higher levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, fibrinogen, and homocysteine than did controls. The homocysteine level distribution of cases was shifted toward higher concentrations (P < 0.05) compared with those in controls. When patients with one-vessel, two-vessel, and three-vessel disease were compared, only levels of fibrinogen and homocysteine were associated with the numbers of vessels involved. Homocysteine level was not correlated to fibrinogen and lipid concentrations. A multiple regression analysis revealed that only age (P = 0.06) and smoking (P= 0.04) were marginally related to homocysteine concentrations. Homocysteine concentrations in cases were significantly different than those in controls, even after adjustment for all covariates (P < 0.006).
Conclusion Hyperhomocysteinemia is independently associated with coronary artery disease in Arab men. Furthermore, fibrinogen concentrations are also an important risk factor for Arab men.
SelhubJMillerJW.The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfation of homocysteine. Am J Clin Nutr1992; 55:131–138.
2.
McCullyKS.Vascular pathology of homocysteinemia: Implication for the pathogenesis of atherosclerosis. Am J Pathol1969; 56:111–128.
3.
DaleryKLussier-CacanSSelhumJDavingnonJLatourYGenestJ.Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol1995; 75:1107–1111.
4.
StampferMJMalinowMRWillettWCNewcomerLMUpsonBUllmannDA prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA1992; 286:877–881.
5.
BrattstromLLindgrenAIsraelssonBMalinowMRNorvingBUpsonBHyperhomocysteinaemia in stroke: Prevalence, cause and relationships to type of stroke and stroke risk factors. Eur J Clin Invest1992; 22:214–221.
6.
MalinowMRNietoJSzkloMChamblessLEBongG.Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. Circulation1993; 87:1107–1113.
7.
MolgaardJMalinowMRLassvikCHolmA-CUpsonBOlssonAG.Hyperhomocysteinemia: An independent risk factor for intermittent claudication. J Intern Med1992; 231:273–279.
8.
Sutton-TyrrellKBostomASelhubJZeigler-JohnsonC.High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation1997; 96:1745–1749.
9.
BousheyCJBeresfordSAAOmennGSMotulskyAG.A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes. JAMA1995; 274:1049–1057.
10.
GartlerSMHornanySKMotulskyAG.Effect of chronologic age on induction of cystathionine synthase, uroporphyrinogen 1 synthase, and glucose-G-phosphate dehydrogenase activities in lymphocytes. Proc Natl Acad Sci USA1981; 78:1416–1419.
11.
MuddSHSkovbyFFebyHLPettigrewKDWilckenBPyeritzREThe natural history of homocysteineuria due to cystathionine beta synthase deficiency. Am J Hum Genet1985; 37:1–31.
12.
GoyettePSumnerJSMilosRDuncanAMVRosenblattDSMatthewsRGHuman methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nature Genet1994; 7:195–200.
13.
SelhubJJacquesPFWilsonPWFRushDRosenbergIH.Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA1993; 270:2693–2698.
14.
DavidoffF.Blood sugar, disease and nondisease. Ann Intern Med1997; 127:235–237.
15.
FriedewaldWTRobertILDonaldSF.Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem1972; 18:499–502.
16.
BeckerUBartlKWahlefeldAW.A functional photometric assay for plasma fibrinogen. Thromb Res1984; 35:475–484.
17.
ForteinLJGenestJ.Measurement of homocysteine in the prediction of arteriosclerosis. Clin Biochem1995; 28:155–162.
18.
ArakiASakoY.Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescent detection. J Chromatogr1987; 422:43–52.
19.
UbbinkJBVermaakWJHBennettJMBeckerPJVan StadenDABissbortS.The prevalence of hyperhomocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr1991; 69:527–534.
20.
Al KatebAHZarzzourWShameahMJuomaM.Coronary risk factor in angiographically assessed patients from Syria. J Cardiovasc Risk1998; 5:31–35.
21.
StamlerJSOsborneJAJarakiORabbaniLEMullinsMSingelDAdverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest1993; 91:308–318.
22.
TsaiJCPerrellaMAYoshizumiMHsiehCMHaberESchlegelRPromotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA1994; 91:6369–6373.
23.
LentzSRSadlerJE.Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest1991; 88:1906–1914.
24.
StarkebaumGHarlanJM.Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest1986; 77:1370–1376.
25.
AssmannGCullenPHeinrichJSchulteH.Hemostatic variables in the prediction of coronary risk: Results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM) Prospective Cardiovascular Münster Study. Isr J Med Sci1996; 32:364–370.
26.
PearsonTALaCavaJWeilHF.Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr1997; 65 (suppl 5):1674S–1682S.
27.
ThomasDPRobertsHR.Hypercoagulability in venous and arterial thrombosis. Ann Intern Med1997; 126:638–644.
28.
de MaatMPPietersmaAKofflardMSluiterWKluftC.Association of plasma fibrinogen levels with coronary disease, smoking, and inflammatory markers. Atherosclerosis1996; 121:185–191.
29.
BennettJSChanCVilaireGMousaSADeGradoWEAgonist-activated alphavbeta3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem1997; 272:8137–8140.
30.
SimonDlXuHOrtleppSRogersCRaoNK.7E3 monoclonal antibody directed against the platelet glycoprotein llb/llla∗ cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol1997; 17:528–535.
31.
WangXLWangJMcCredieRMWilckenDE.Polymorphisms of factor V, factor VII, and fibrinogen genes: Relevance to the severity of coronary artery disease. Arterioscler Thromb Vasc Biol1997; 17:246–251.
